Sigma Planning’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$266K Buy
19,944
+6,008
+43% +$86.9K 0.01% 1110
2026
Q2
$207K Buy
13,936
+612
+5% +$6.59K 0.01% 1315
2026
Q1
$113K Sell
13,324
-289
-2% -$3.16K ﹤0.01% 1271
2025
Q4
$154K Buy
13,613
+1,146
+9% +$14.2K ﹤0.01% 1240
2025
Q3
$187K Buy
12,467
+1,146
+10% +$16.7K 0.01% 1226
2025
Q2
$160K Buy
11,321
+459
+4% +$8.18K ﹤0.01% 1189
2025
Q1
$261K Buy
10,862
+2,661
+32% +$93.8K 0.01% 1012
2024
Q4
$306K Sell
8,201
-3
-0% -$140 0.01% 916
2024
Q3
$410K Sell
8,204
-382
-4% -$14.9K 0.01% 816
2024
Q2
$298K Sell
8,586
-184
-2% -$7.28K 0.01% 927
2024
Q1
$480K Buy
8,770
+2,352
+37% +$116K 0.02% 781
2023
Q4
$275K Sell
6,418
-6,447
-50% -$200K 0.02% 656
2023
Q3
$335K Sell
12,865
-5,917
-32% -$123K 0.01% 879
2023
Q2
$449K Sell
18,782
-425
-2% -$7.32K 0.02% 773
2023
Q1
$262K Buy
19,207
+59
+0.3% +$939 0.01% 1053
2022
Q4
$266K Buy
+19,148
New +$270K 0.01% 1017

Other funds holding BHVN

Sigma Planning's BHVN Position: Q3 2026 in Review

Sigma Planning increased its Biohaven (BHVN) stake by 43% in Q3 2026, buying an estimated $86.9K and bringing the position to 19,944 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #1110.

Sigma Planning first reported a position in BHVN in Q4 2022 and has held it in 16 quarters since. The position peaked at $480K in Q1 2024. 216 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Sigma Planning held 19,944 shares of Biohaven worth $266K as of Q3 2026.
  • Sigma Planning bought 6,008 Biohaven shares in Q3 2026, an estimated $86.9K.
  • Biohaven made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #1110 holding.
  • Sigma Planning first reported a position in Biohaven in Q4 2022 and has held it in 16 quarters since.
  • Sigma Planning's Biohaven position peaked at $480K in Q1 2024.
  • 216 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.